ARTICLE | Company News
Dyax, HTS Bio deal
February 20, 2001 8:00 AM UTC
Under a non-exclusive licensing agreement, DYAX will receive pre-market access to HTS’s grating-coupled surface plasmon resonance (SPR) array system, and DYAX will grant HTS a license to use its phage...